Heartflow (NASDAQ:HTFL) Trading 7.1% Higher – What’s Next?

Heartflow, Inc. (NASDAQ:HTFLGet Free Report) shares traded up 7.1% during mid-day trading on Friday . The stock traded as high as $48.30 and last traded at $48.7330. Approximately 880,384 shares changed hands during trading, a decline of 43% from the average daily volume of 1,548,324 shares. The stock had previously closed at $45.49.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HTFL. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. JPMorgan Chase & Co. raised their price target on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Robert W. Baird set a $45.00 price objective on shares of Heartflow in a report on Friday, August 14th. Wells Fargo & Company upped their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Finally, Stifel Nicolaus lifted their price target on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $44.88.

Get Our Latest Report on Heartflow

Heartflow Stock Up 9.1%

The company has a market capitalization of $4.32 billion and a price-to-earnings ratio of -27.13. The business’s 50-day moving average is $35.08 and its 200-day moving average is $30.65.

Heartflow (NASDAQ:HTFLGet Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s quarterly revenue was up 47.7% on a year-over-year basis. As a group, analysts expect that Heartflow, Inc. will post -0.75 EPS for the current year.

Insider Buying and Selling at Heartflow

In other Heartflow news, CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer owned 457,935 shares in the company, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the transaction, the insider directly owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 208,765 shares of company stock valued at $8,444,106. 7.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Heartflow

A number of large investors have recently bought and sold shares of the business. TrueMark Investments LLC grew its stake in Heartflow by 1.4% in the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after acquiring an additional 379 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Heartflow in the fourth quarter valued at about $27,000. Strs Ohio increased its stake in shares of Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after purchasing an additional 1,200 shares in the last quarter. Russell Investments Group Ltd. acquired a new position in shares of Heartflow during the 4th quarter worth about $45,000. Finally, Legal & General Group Plc purchased a new position in Heartflow in the 3rd quarter valued at about $59,000.

Heartflow Company Profile

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFRCT).

Further Reading

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.